摘要
上市公司数据是行业发展情况的重要指标。本文以我国药品零售行业上市的4家公司2015年年报数据为模型,基于因子分析法对其收入增长、盈利能力、费用控制、资本运作和战略实施情况进行综合分析,挖掘数据背后的原因,试图发现一些行业变迁的新动向,为药品零售企业提升自身竞争力提供参考。
The data from the listed company are some important indicators for the industry development. The revenue growth, profitability, cost control, capital operation and strategic implementation were comprehensively analyzed based on the factor analysis method by taking the annual reports of four Chinese pharmaceutical retail enterprises in 2015 as a model so as to unearth the reasons behind the data, find the new trends of industry change and provide some references for the pharmaceutical retail enterprises in improving competitiveness.
作者
秦银兵
QIN Yinbing(Sinopharm Group Co. Ltd., Shanghai 200051, China)
出处
《上海医药》
CAS
2016年第19期67-71,共5页
Shanghai Medical & Pharmaceutical Journal
关键词
药品零售企业
因子分析
竞争力
phannaceutical retail enterprises
factor analysis
comprehensive competitiveness